3-Fluoro-5-[(1S,3R)-2,2,3-trifluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxybenzonitrile

ID: ALA4453227

Chembl Id: CHEMBL4453227

PubChem CID: 117947096

Max Phase: Preclinical

Molecular Formula: C17H11F4NO4S

Molecular Weight: 401.34

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)c1ccc(Oc2cc(F)cc(C#N)c2)c2c1[C@H](O)C(F)(F)[C@@H]2F

Standard InChI:  InChI=1S/C17H11F4NO4S/c1-27(24,25)12-3-2-11(13-14(12)16(23)17(20,21)15(13)19)26-10-5-8(7-22)4-9(18)6-10/h2-6,15-16,23H,1H3/t15-,16+/m1/s1

Standard InChI Key:  VHWGCWVDVWACAH-CVEARBPZSA-N

Associated Targets(Human)

EPAS1 Tclin Endothelial PAS domain-containing protein 1 (498 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UGT2B17 Tbio UDP-glucuronosyltransferase 2B17 (197 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 401.34Molecular Weight (Monoisotopic): 401.0345AlogP: 3.59#Rotatable Bonds: 3
Polar Surface Area: 87.39Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.31CX Basic pKa: CX LogP: 2.32CX LogD: 2.32
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.79Np Likeness Score: -0.85

References

1. Xu R, Wang K, Rizzi JP, Huang H, Grina JA, Schlachter ST, Wang B, Wehn PM, Yang H, Dixon DD, Czerwinski RM, Du X, Ged EL, Han G, Tan H, Wong T, Xie S, Josey JA, Wallace EM..  (2019)  3-[(1S,2S,3R)-2,3-Difluoro-1-hydroxy-7-methylsulfonylindan-4-yl]oxy-5-fluorobenzonitrile (PT2977), a Hypoxia-Inducible Factor 2α (HIF-2α) Inhibitor for the Treatment of Clear Cell Renal Cell Carcinoma.,  62  (15): [PMID:31282155] [10.1021/acs.jmedchem.9b00719]

Source